Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Bouillette-Marussig
GTL001, a Therapeutic Vaccine for Women Infected With Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Clinical Cancer Research
Cancer Research
Oncology
Related publications
GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression
PLoS ONE
Multidisciplinary
Human Papillomavirus Type 16 and 18 Viral Loads as Predictors Associated With Abnormal Cervical Cytology Among Women in Saudi Arabia
Heliyon
Multidisciplinary
A Novel Vaccine for Cervical Cancer: Quadrivalent Human Papillomavirus (Types 6, 11, 16 and 18) Recombinant Vaccine (Gardasil®)
Therapeutics and Clinical Risk Management
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
Drugs
Pharmacology
A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
Journal of Clinical Microbiology
Microbiology
Cytomegalovirus Vaccine: Phase II Clinical Trial Results
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Estimating the Long-Term Impact of a Prophylactic Human Papillomavirus 16/18 Vaccine on the Burden of Cervical Cancer in the UK
British Journal of Cancer
Cancer Research
Oncology
Gene Therapy for Pain: Results of a Phase I Clinical Trial
Annals of Neurology
Neurology
